Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001121
Filing Date
2023-05-12
Accepted
2023-05-12 17:27:00
Documents
68
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zura-20230331x10q.htm   iXBRL 10-Q 1306010
2 EX-10.28 zura-20230331xex10d28.htm EX-10.28 32082
3 EX-31.1 zura-20230331xex31d1.htm EX-31.1 12529
4 EX-31.2 zura-20230331xex31d2.htm EX-31.2 12541
5 EX-32.1 zura-20230331xex32d1.htm EX-32.1 7094
6 EX-32.2 zura-20230331xex32d2.htm EX-32.2 7121
  Complete submission text file 0001410578-23-001121.txt   5963118

Data Files

Seq Description Document Type Size
7 EX-101.SCH zura-20230331.xsd EX-101.SCH 61224
8 EX-101.CAL zura-20230331_cal.xml EX-101.CAL 32107
9 EX-101.DEF zura-20230331_def.xml EX-101.DEF 239297
10 EX-101.LAB zura-20230331_lab.xml EX-101.LAB 482358
11 EX-101.PRE zura-20230331_pre.xml EX-101.PRE 382888
62 EXTRACTED XBRL INSTANCE DOCUMENT zura-20230331x10q_htm.xml XML 787451
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40598 | Film No.: 23917187
SIC: 2836 Biological Products, (No Diagnostic Substances)